MovDisordV3, Main, Exploration, bibRecordById, pubmed:7910949

Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis

Identifieur interne : 005A60 ( Main/Exploration ); précédent : 005A59; suivant : 005A61

Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis

Auteurs : G. Arnold [Allemagne] ; C. Trenkwalder [Allemagne] ; J. Schwarz [Allemagne] ; W. H. Oertel [Allemagne]

Source :

Movement Disorders [ 0885-3185 ] ; 1994.

RBID : ISTEX:97F6A5E804D85C999B8E50DF2A1DA3BBBC7D067F

English descriptors

KwdEn :
- Aged, Antiparkinson Agents (administration & dosage), Antiparkinson Agents (adverse effects), Antipsychotic Agents (adverse effects), Antipsychotic Agents (therapeutic use), Dibenzothiepins (adverse effects), Dibenzothiepins (therapeutic use), Dose-Response Relationship, Drug, Drug Administration Schedule, Dyskinesia, Drug-Induced (etiology), Female, Humans, Levodopa (administration & dosage), Levodopa (adverse effects), Male, Muscle Rigidity (etiology), Neurologic Examination (drug effects), Parkinson Disease (drug therapy), Psychoses, Substance-Induced (drug therapy), Tremor (drug therapy).
MESH :
- chemical , administration & dosage : Antiparkinson Agents, Levodopa.
- chemical , adverse effects : Antiparkinson Agents, Antipsychotic Agents, Dibenzothiepins, Levodopa.
- chemical , therapeutic use : Antipsychotic Agents, Dibenzothiepins.
- drug effects : Neurologic Examination.
- drug therapy : Parkinson Disease, Psychoses, Substance-Induced, Tremor.
- etiology : Dyskinesia, Drug-Induced, Muscle Rigidity.
- Aged, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Humans, Male.

Url:

https://api.istex.fr/document/97F6A5E804D85C999B8E50DF2A1DA3BBBC7D067F/fulltext/pdf

DOI: 10.1002/mds.870090224

Affiliations:

Le document en format XML

<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis</title>
<author><name sortKey="Arnold, G" sort="Arnold, G" uniqKey="Arnold G" first="G." last="Arnold">G. Arnold</name>
</author>
<author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name>
</author>
<author><name sortKey="Schwarz, J" sort="Schwarz, J" uniqKey="Schwarz J" first="J." last="Schwarz">J. Schwarz</name>
</author>
<author><name sortKey="Oertel, W H" sort="Oertel, W H" uniqKey="Oertel W" first="W. H." last="Oertel">W. H. Oertel</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:97F6A5E804D85C999B8E50DF2A1DA3BBBC7D067F</idno>
<date when="1994" year="1994">1994</date>
<idno type="doi">10.1002/mds.870090224</idno>
<idno type="url">https://api.istex.fr/document/97F6A5E804D85C999B8E50DF2A1DA3BBBC7D067F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">003A99</idno>
<idno type="wicri:Area/Istex/Curation">003A99</idno>
<idno type="wicri:Area/Istex/Checkpoint">003D95</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Arnold G:zotepine:reversibly:induces</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:7910949</idno>
<idno type="wicri:Area/PubMed/Corpus">004B43</idno>
<idno type="wicri:Area/PubMed/Curation">004B43</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004A40</idno>
<idno type="wicri:Area/Ncbi/Merge">004809</idno>
<idno type="wicri:Area/Ncbi/Curation">004809</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004809</idno>
<idno type="wicri:doubleKey">0885-3185:1994:Arnold G:zotepine:reversibly:induces</idno>
<idno type="wicri:Area/Main/Merge">008C51</idno>
<idno type="wicri:Area/Main/Curation">005A60</idno>
<idno type="wicri:Area/Main/Exploration">005A60</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis</title>
<author><name sortKey="Arnold, G" sort="Arnold, G" uniqKey="Arnold G" first="G." last="Arnold">G. Arnold</name>
<affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Klinikum Grosshadern, University of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
<author><name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name>
<affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Klinikum Grosshadern, University of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
<author><name sortKey="Schwarz, J" sort="Schwarz, J" uniqKey="Schwarz J" first="J." last="Schwarz">J. Schwarz</name>
<affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Klinikum Grosshadern, University of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
<author><name sortKey="Oertel, W H" sort="Oertel, W H" uniqKey="Oertel W" first="W. H." last="Oertel">W. H. Oertel</name>
<affiliation wicri:level="4"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurology, Klinikum Grosshadern, University of Munich, Munich</wicri:regionArea>
<placeName><region type="land" nuts="1">Bavière</region>
<region type="district" nuts="2">District de Haute-Bavière</region>
<settlement type="city">Munich</settlement>
</placeName>
<orgName type="university">Université Louis-et-Maximilien de Munich</orgName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="1994">1994</date>
<biblScope unit="vol">9</biblScope>
<biblScope unit="issue">2</biblScope>
<biblScope unit="page" from="238">238</biblScope>
<biblScope unit="page" to="240">240</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">97F6A5E804D85C999B8E50DF2A1DA3BBBC7D067F</idno>
<idno type="DOI">10.1002/mds.870090224</idno>
<idno type="ArticleID">MDS870090224</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term>
<term>Antiparkinson Agents (administration & dosage)</term>
<term>Antiparkinson Agents (adverse effects)</term>
<term>Antipsychotic Agents (adverse effects)</term>
<term>Antipsychotic Agents (therapeutic use)</term>
<term>Dibenzothiepins (adverse effects)</term>
<term>Dibenzothiepins (therapeutic use)</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Dyskinesia, Drug-Induced (etiology)</term>
<term>Female</term>
<term>Humans</term>
<term>Levodopa (administration & dosage)</term>
<term>Levodopa (adverse effects)</term>
<term>Male</term>
<term>Muscle Rigidity (etiology)</term>
<term>Neurologic Examination (drug effects)</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Psychoses, Substance-Induced (drug therapy)</term>
<term>Tremor (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Antiparkinson Agents</term>
<term>Antipsychotic Agents</term>
<term>Dibenzothiepins</term>
<term>Levodopa</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Antipsychotic Agents</term>
<term>Dibenzothiepins</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Neurologic Examination</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
<term>Psychoses, Substance-Induced</term>
<term>Tremor</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Dyskinesia, Drug-Induced</term>
<term>Muscle Rigidity</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Dose-Response Relationship, Drug</term>
<term>Drug Administration Schedule</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
<region><li>Bavière</li>
<li>District de Haute-Bavière</li>
</region>
<settlement><li>Munich</li>
</settlement>
<orgName><li>Université Louis-et-Maximilien de Munich</li>
</orgName>
</list>
<tree><country name="Allemagne"><region name="Bavière"><name sortKey="Arnold, G" sort="Arnold, G" uniqKey="Arnold G" first="G." last="Arnold">G. Arnold</name>
</region>
<name sortKey="Oertel, W H" sort="Oertel, W H" uniqKey="Oertel W" first="W. H." last="Oertel">W. H. Oertel</name>
<name sortKey="Schwarz, J" sort="Schwarz, J" uniqKey="Schwarz J" first="J." last="Schwarz">J. Schwarz</name>
<name sortKey="Trenkwalder, C" sort="Trenkwalder, C" uniqKey="Trenkwalder C" first="C." last="Trenkwalder">C. Trenkwalder</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 005A60 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 005A60 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:97F6A5E804D85C999B8E50DF2A1DA3BBBC7D067F
   |texte=   Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis
}}

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024

Movement Disorders (revue)

Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis

Zotepine reversibly induces akinesia and rigidity in Parkinson's disease patients with resting tremor or drug‐induced psychosis

Source :

English descriptors

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

	Movement Disorders (revue)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.